PATH vs VYGR
Uipath Inc (PATH) versus Voyager Therapeutics Inc (VYGR) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported VYGR revenue for 2024-12-31 was $80.0M. Net income was -$65.0M. Revenue was down 68.0% from 2023-12-31 to 2024-12-31. VYGR currently screens at market cap $225.4M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. VYGR currently screens at market cap $225.4M.
Not investment advice. Open the PATH and VYGR stock pages for the full models.
Not investment advice.